Abstract
By pretreatment with concanavalin A (Con A) both in vivo and in vitro genetically susceptible mice and their cultured macrophages have been converted to animals and cells which are phenotypically resistant to mouse hepatitus virus (MHV). Con A at 1.0 mg/mouse decreased the mortality from 100% to less than 40% by inducing a prominent inflammatory response, increasing the number of macrophages in the virus inoculation site, and producing a population of macrophages not uniformly susceptible to the virus. In addition, mediators derived from Con A-treated spleen cells conferred resistance to normally susceptible syngeneic macrophages to 100 TCID50 of MHV.
Full Text
The Full Text of this article is available as a PDF (1.4 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Weiser W., Bang F. B. Macrophages genetically resistant to mouse hepatitis virus converted in vitro to susceptible macrophages. J Exp Med. 1976 Mar 1;143(3):690–695. doi: 10.1084/jem.143.3.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weiser W., Vellisto I., Bang F. B. Congenic strains of mice susceptible and resistant to mouse hepatitis virus. Proc Soc Exp Biol Med. 1976 Sep;152(4):499–502. doi: 10.3181/00379727-152-39426. [DOI] [PubMed] [Google Scholar]
- Wheelock E. F. Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin. Science. 1965 Jul 16;149(3681):310–311. doi: 10.1126/science.149.3681.310. [DOI] [PubMed] [Google Scholar]
- Youngner J. S., Salvin S. B. Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity. J Immunol. 1973 Dec;111(6):1914–1922. [PubMed] [Google Scholar]